Search

Your search keyword '"J.-M. Pawlotsky"' showing total 25 results

Search Constraints

Start Over You searched for: Author "J.-M. Pawlotsky" Remove constraint Author: "J.-M. Pawlotsky" Topic gastroenterology Remove constraint Topic: gastroenterology
25 results on '"J.-M. Pawlotsky"'

Search Results

3. 1094 100% SVR IN IL28B CC PATIENTS TREATED WITH 12 WEEKS OF TELAPREVIR, PEGINTERFERON AND RIBAVIRIN IN THE PROVE2 TRIAL

4. 1190 SILEN-C2: EARLY ANTIVIRAL ACTIVITY AND SAFETY OF BI 201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (PEGIFN/RBV) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO PEGIFN/RBV

5. 620 Presence of CD4-positive cells in the portal tract on pretreatment liver biopsy is associated with early viral reduction during antiviral treatment of HCV

6. 771 SEQUENCE ANALYSIS OF THE HBV PreC/C REGION BY ULTRA-DEEP PYROSEQUENCING AS A PREDICTOR OF ADEFOVIR TREATMENT OUTCOME IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B

7. 60 SVR12 RATES AND SAFETY OF TRIPLE THERAPY INCLUDING TELAPREVIR OR BOCEPREVIR IN 221 CIRRHOTIC NON RESPONDERS TREATED IN THE FRENCH EARLY ACCESS PROGRAM (ANRS CO20-CUPIC)

10. 363 VIROLOGICAL CHARACTERISTICS OF A LARGE PROSPECTIVE COHORT OF PATIENTS WITH CHRONIC HEPATITIS B NEWLY SEEN IN HEPATOLOGY REFERENCE CENTERS IN FRANCE IN 2008-2010

11. 4 SVR WITH TELAPREVIR, PEGINTERFERON ALFA-2A AND RIBAVIRIN IN HCV PATIENTS WITH WELL-CHARACTERIZED PRIOR NULL RESPONSE, PARTIAL RESPONSE, VIRAL BREAKTHROUGH OR RELAPSE AFTER PR

12. 615 PROSPECTIVE EVALUATION OF LIVER STIFFNESS DYNAMICS DURING AND AFTER PEGINTERFERON ALPHA-RIBAVIRIN TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

13. 58 TREATMENT OF CHRONIC HEPATITIS C WITH TELAPREVIR (TVR) IN COMBINATION WITH PEGINTERFERON-ALFA-2A WITH OR WITHOUT RIBAVIRIN: FURTHER INTERIM ANALYSIS RESULTS OF THE PROVE2 STUDY

14. 793 DYNAMICS OF LIVER STIFFNESS DURING PEGINTERFREON ALPHA-RIBAVIRIN TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

15. [597] EVOLUTION OF LIVER STIFFNESS MEASUREMENT DURING ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C

16. [17] CANNABIS USE AS AN INDEPENDENT PREDICTOR OF SEVERE STEATOSIS DURING CHRONIC HEPATITIS C

17. Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: Evidence for a role of HCV genotype 3 in steatosis

19. Histological evaluation of alpha 2a interferon monotherapy in patients with chronic hepatitis C and repeatedly normal aminotransferase levels. A randomized study

22. Post-transplant lymphoproliferative disorders (PTLD) after liver transplantation (LT). Role of HCV infection

23. Alcohol intake, even moderate, induces increased histological activity and fibrosis in patients with chronic active hepatitis C

24. Liver iron overload in patients with chronic active hepatitis C. Prevalence, role of the hemochromatosis gene and relation with hepatic histological lesions

Catalog

Books, media, physical & digital resources